1. Mogensen CE, Keane WF, Bennett PH, Jerums G, Parving HH, Passa P, Steffes MW, Striker GE, Viberti GC. Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet. 1995. 346:1080–1084.
2. Gilbert RE, Tsalamandris C, Bach LA, Goodall I, Young V, Seeman E, Murray RM. Glycemic control and the rate of progression o early diabetic kidney disease: a nine year longitudinal study. Kidney Int. 1993. 44:855–859.
3. Mogensen CE. Progression of nephropathy in long-term diabetic with proteinuria and effect of initial anti-hypertensive treatment. Scand J Clin Lab Invest. 1976. 36:383–388.
4. Cooper ME. Renal protection and ACE inhibition in microalbuminuric type I and type II diabetic patients. J Hypertens. 1996. 14:S11–S14.
5. Nicholas SB, Kawano Y, Wakino S, Collins AR, Hsueh WA. Expression and function of peroxisome proliferators-activated receptor-r in mesangial cells. Hypertension. 2001. 37:722–727.
6. New JP, Middleton RJ, Klebe B, Farmer CK, de Lusignan S, Stevens PE, O'Donoqhue DJ. Assessing the prevalence, monitoring and management of chronic kidney disease in patients with diabetes compared with those without diabetes in general practice. Diabet Med. 2007. 24:364–369.